MiMedx: Is Bankruptcy Imminent Following Appointment Of Former Lehman Brothers CEO?

7/6/18

I recently sent my Dad a copy of Bad Blood, by John Carreyou of the WSJ. The book details the incredible fraud, criminality, disgusting behavior, etc. that went on at Theranos (THERA) for years. The company is a shell of its former self, has basically ceased making product, is under investigation by the federal government, and Carreyou predicts that the company won't exist in a few months. The company used aggressive legal tactics to silence and intimidate people. Just read the book. And/or listen to some of the interviews Carreyou has done. I haven't read the book, but listened to several podcasts on the subject.

This article is obviously not about Theranos. That said, I led this article with Theranos because MiMedx [MDXG] expert, and longtime short seller Marc Cohodes, has described MiMedx as being like Theranos, but on a whole other level of fraud! This is an unbelievable statement! I mean, just look at the title of Carreyou's book! Bad Blood! When I heard Cohodes say that MiMedx was on a whole other level, I knew I was going to be instantly intrigued and had to learn more.

Look, I've got a philosophy degree. I have a different investing “style.” I really haven't done any sort of investing in years. I don't like BS. Hate it. I've been busy. I have a life. I also just haven't felt like risking any capital in the markets. Investing is something I do mostly for fun and read about because it interests me.

READ FULL ARTICLE HERE

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.